A 58-year-old man with a history of hypertension presents with palpitations and is found to have atrial fibrillation with a rapid ventricular response (HR 140/min). An ECG shows the characteristic action potential phases of a ventricular myocyte. The structure marked **C** in the diagram represents the phase responsible for excitation-contraction coupling in cardiac muscle. Which of the following drugs would be most appropriate for rate control in this patient, given its mechanism of action on this phase?

Explanation

## Why Verapamil is right Verapamil is a Class IV antiarrhythmic that selectively blocks L-type calcium channels — the ion channels that mediate Phase 2 (the plateau phase marked **C**). During Phase 2, L-type Ca2+ influx is essential for both the plateau potential and excitation-contraction coupling via calcium-induced calcium release from the sarcoplasmic reticulum. By blocking these channels, verapamil slows conduction through the AV node (which relies heavily on L-type Ca2+ channels) and reduces the ventricular rate in atrial fibrillation. This is the mechanism-based answer directly tied to the labeled structure. (Guyton & Hall 14e Ch 9; KD Tripathi 9e Ch 38) ## Why each distractor is wrong - **Procainamide**: A Class IA antiarrhythmic that blocks Na+ channels during Phase 0 (rapid depolarization), not Phase 2. While it can reduce automaticity, it does not act on the L-type Ca2+ channels responsible for the plateau phase and is not first-line for rate control in atrial fibrillation. - **Amiodarone**: A Class III antiarrhythmic that primarily blocks K+ channels during Phase 3 (repolarization), prolonging the action potential duration and refractory period. Although it has some Ca2+ channel-blocking properties, its primary mechanism is K+ channel blockade, not selective L-type Ca2+ channel inhibition during Phase 2. - **Esmolol**: A beta-blocker that reduces heart rate through decreased sympathetic tone and slower AV nodal conduction via β1-receptor blockade. It does not directly block L-type Ca2+ channels and is not the mechanism-based answer for Phase 2 physiology. **High-Yield:** Phase 2 plateau = L-type Ca2+ channels = Class IV antiarrhythmics (verapamil, diltiazem) = rate control in SVT/AFib; contraindicated in HF and with beta-blockers. [cite:Guyton & Hall 14e Ch 9; KD Tripathi 9e Ch 38]